Q3 2024 |
298 |
$7.48B |
+$295M |
-$378M |
-$83.3M |
PGR, LMT, DEO, CB, LIN
|
13F-HR |
10/31/2024, 03:17 PM |
Q2 2024 |
299 |
$6.93B |
+$361M |
-$559M |
-$198M |
PGR, CB, ADI, PEP, LIN
|
13F-HR |
7/1/2024, 01:15 PM |
Q1 2024 |
296 |
$7.44B |
+$400M |
-$471M |
-$70.7M |
FAST, PGR, MSFT, SNA, LIN
|
13F-HR |
4/1/2024, 03:35 PM |
Q4 2023 |
294 |
$7.07B |
+$478M |
-$446M |
+$32.1M |
PGR, SNA, FAST, MSFT, PEP
|
13F-HR |
11/5/2024, 02:58 PM |
Q3 2023 |
290 |
$6.46B |
+$143M |
-$230M |
-$87.3M |
PGR, PEP, MSFT, SNA, LIN
|
13F-HR |
10/10/2023, 10:55 AM |
Q2 2023 |
298 |
$6.86B |
+$121M |
-$237M |
-$116M |
PEP, SNA, MSFT, ADI, FAST
|
13F-HR |
7/3/2023, 09:26 AM |
Q1 2023 |
301 |
$6.79B |
+$414M |
-$503M |
-$88.3M |
PEP, PGR, ADI, SNA, LMT
|
13F-HR |
4/4/2023, 04:02 PM |
Q4 2022 |
305 |
$6.7B |
+$566M |
-$438M |
+$128M |
PEP, PGR, LMT, DEO, CB
|
13F-HR |
1/3/2023, 08:18 PM |
Q3 2022 |
298 |
$5.99B |
+$203M |
-$194M |
+$8.73M |
PEP, PGR, DEO, PAYX, SNA
|
13F-HR |
10/3/2022, 10:48 AM |
Q2 2022 |
310 |
$6.42B |
+$317M |
-$180M |
+$137M |
PEP, PGR, DEO, PAYX, LMT
|
13F-HR |
7/11/2022, 06:14 PM |
Q1 2022 |
310 |
$7.15B |
+$470M |
-$489M |
-$19.1M |
DEO, PAYX, PEP, FAST, MSFT
|
13F-HR |
4/4/2022, 09:44 AM |
Q4 2021 |
306 |
$7.53B |
+$74.2M |
-$407M |
-$333M |
DEO, FAST, PEP, PAYX, MSFT
|
13F-HR |
1/4/2022, 11:29 AM |
Q3 2021 |
299 |
$7.13B |
+$136M |
-$418M |
-$282M |
DEO, PEP, PAYX, MSFT, FAST
|
13F-HR |
10/4/2021, 11:20 AM |
Q2 2021 |
302 |
$7.52B |
+$255M |
-$192M |
+$62.9M |
PEP, DEO, LIN, PAYX, SNA
|
13F-HR |
7/1/2021, 02:18 PM |
Q1 2021 |
300 |
$7.12B |
+$323M |
-$314M |
+$9.18M |
SNA, LIN, PEP, PII, FAST
|
13F-HR |
4/5/2021, 09:39 AM |
Q4 2020 |
302 |
$6.72B |
+$251M |
-$398M |
-$147M |
GGG, PEP, LIN, FAST, PAYX
|
13F-HR |
1/25/2021, 11:30 AM |
Q3 2020 |
293 |
$6.15B |
+$156M |
-$288M |
-$131M |
PEP, GGG, LIN, NSRGY, FAST
|
13F-HR |
10/19/2020, 04:05 PM |
Q2 2020 |
291 |
$5.99B |
+$165M |
-$239M |
-$73.6M |
MSFT, PEP, FAST, LIN, NSRGY
|
13F-HR |
7/1/2020, 03:20 PM |
Q1 2020 |
291 |
$5.26B |
+$642M |
-$610M |
+$31.7M |
PEP, MSFT, NSRGY, LIN, DEO
|
Restatement |
6/3/2020, 12:26 PM |
Q4 2019 |
290 |
$5.97B |
+$133M |
-$133M |
-$871K |
PEP, DEO, MSFT, LIN, PAYX
|
Restatement |
6/2/2020, 02:28 PM |
Q3 2019 |
286 |
$6.41B |
+$185M |
-$137M |
+$47.4M |
PEP, NXPI, MSFT, DEO, NSRGY
|
13F-HR |
10/15/2019, 03:53 PM |
Q2 2019 |
290 |
$6.25B |
+$330M |
-$244M |
+$85.7M |
PEP, DEO, MSFT, NXPI, LIN
|
Restatement |
6/2/2020, 09:56 AM |
Q1 2019 |
293 |
$5.92B |
+$520M |
-$587M |
-$67.6M |
DEO, PEP, MSFT, PAYX, NXPI
|
13F-HR |
4/16/2019, 11:55 AM |
Q4 2018 |
303 |
$5.32B |
+$513M |
-$324M |
+$189M |
JNJ, DEO, PEP, MSFT, FAST
|
13F-HR |
1/4/2019, 03:18 PM |
Q3 2018 |
309 |
$5.87B |
+$365M |
-$368M |
-$2.53M |
JNJ, MSFT, PGR, FAST, DEO
|
13F-HR |
10/24/2018, 07:20 PM |
Q2 2018 |
311 |
$5.69B |
+$349M |
-$183M |
+$165M |
DWDP, DEO, MSFT, PII, JNJ
|
13F-HR |
7/12/2018, 09:25 AM |
Q1 2018 |
226 |
$5.41B |
+$363M |
-$249M |
+$114M |
DWDP, JNJ, DEO, MSFT, PEP
|
13F-HR |
4/4/2018, 12:19 PM |
Q4 2017 |
241 |
$5.48B |
+$280M |
-$171M |
+$109M |
JNJ, PEP, DEO, PII, FAST
|
13F-HR |
1/8/2018, 01:33 PM |
Q3 2017 |
239 |
$5.22B |
+$461M |
-$264M |
+$197M |
JNJ, PEP, DEO, PII, FAST
|
13F-HR |
10/13/2017, 10:21 AM |
Q2 2017 |
238 |
$4.92B |
+$434M |
-$73.6M |
+$360M |
JNJ, PEP, NTRS, DEO, FAST
|
13F-HR |
7/11/2017, 03:44 PM |
Q1 2017 |
235 |
$4.48B |
+$371M |
-$213M |
+$158M |
JNJ, PEP, DEO, MSFT, CL
|
13F-HR |
4/6/2017, 04:49 PM |
Q4 2016 |
235 |
$4.12B |
+$356M |
-$150M |
+$206M |
JNJ, PEP, NTRS, CVX, MSFT
|
13F-HR |
2/14/2017, 03:41 PM |
Q3 2016 |
223 |
$3.83B |
+$355M |
-$205M |
+$150M |
JNJ, PEP, DEO, LLTC, MSFT
|
13F-HR |
11/3/2016, 06:09 PM |
Q2 2016 |
230 |
$3.64B |
+$329M |
-$139M |
+$191M |
JNJ, PEP, CVX, DEO, CB
|
13F-HR |
7/26/2016, 11:06 AM |
Q1 2016 |
231 |
$3.34B |
+$345M |
-$195M |
+$151M |
PEP, JNJ, CVX, DEO, MSFT
|
13F-HR |
5/4/2016, 12:20 PM |
Q4 2015 |
248 |
$3.06B |
+$245M |
-$42.1M |
+$203M |
PEP, JNJ, MSFT, DEO, CVX
|
13F-HR |
2/2/2016, 06:32 PM |
Q3 2015 |
238 |
$2.74B |
+$307M |
-$159M |
+$148M |
PEP, JNJ, DEO, MSFT, NTRS
|
13F-HR |
11/4/2015, 01:35 PM |
Q2 2015 |
242 |
$2.75B |
+$219M |
-$43.1M |
+$176M |
PEP, JNJ, CVX, NTRS, MSFT
|
13F-HR |
7/17/2015, 02:49 PM |
Q1 2015 |
240 |
$2.65B |
+$370M |
-$214M |
+$156M |
PEP, JNJ, CVX, KRFT, ARCC
|
13F-HR |
4/28/2015, 01:46 PM |
Q4 2014 |
247 |
$2.45B |
+$214M |
-$81M |
+$133M |
JNJ, PEP, CVX, MMM, MSFT
|
13F-HR |
1/28/2015, 05:58 PM |
Q3 2014 |
258 |
$2.24B |
+$197M |
-$91.8M |
+$105M |
JNJ, PEP, CVX, MSFT, LMT
|
13F-HR |
10/20/2014, 06:59 PM |
Q2 2014 |
257 |
$2.19B |
+$251M |
-$102M |
+$149M |
JNJ, CVX, PEP, ARCC, DEO
|
13F-HR |
7/21/2014, 03:16 PM |
Q1 2014 |
252 |
$1.97B |
+$283M |
-$118M |
+$165M |
JNJ, PEP, CVX, ARCC, EMR
|
13F-HR |
5/7/2014, 01:01 PM |
Q4 2013 |
255 |
$1.81B |
$0 |
$0 |
|
CVX, JNJ, ARCC, PEP, EMR
|
13F-HR |
2/4/2014, 03:22 PM |